{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T14:44:07Z","timestamp":1783003447566,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.clml.2024.12.018","type":"journal-article","created":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T17:36:54Z","timestamp":1736271414000},"page":"e319-e335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Myeloid Neoplasms: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9609-6160","authenticated-orcid":false,"given":"Moazzam","family":"Shahzad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4052-7339","authenticated-orcid":false,"given":"Muhammad Kashif","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Fareed","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Kasaeian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iman Menbari","family":"Oskouie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarmad Zaman","family":"Warraich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Basharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif","family":"Butt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheen","family":"Zaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqra","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V.","family":"Jaglal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Umair","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.clml.2024.12.018_bib0001","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1309\/NQ3PMV4U8YV39JWJ","article-title":"Therapy-related myelodysplastic syndrome: morphologic subclassification may not be clinically relevant","volume":"127","author":"Singh","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"9","key":"10.1016\/j.clml.2024.12.018_bib0002","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc.2017.60","article-title":"Therapy-related myeloid neoplasms: when genetics and environment collide","volume":"17","author":"McNerney","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clml.2024.12.018_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102060","article-title":"Trends in risk for therapy-related myelodysplastic syndrome\/acute myeloid leukemia after initial chemo\/immunotherapy for common and rare lymphoid neoplasms, 2000-2018","volume":"61","author":"Morton","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"24","key":"10.1016\/j.clml.2024.12.018_bib0004","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1158\/0008-5472.CAN-12-1728","article-title":"Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms","volume":"72","author":"Choi","year":"2012","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.clml.2024.12.018_bib0005","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1136\/jmedgenet-2011-100674","article-title":"Germline mutations in the DNA damage response genes BRCA1, BRCA2, BARD1 and TP53 in patients with therapy related myeloid neoplasms","volume":"49","author":"Schulz","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/j.clml.2024.12.018_bib0006","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cancergen.2021.05.001","article-title":"Therapy-related acute myeloid leukemia with KMT2A-SNX9 gene fusion associated with a hyperdiploid karyotype after hemophagocytic lymphohistiocytosis","volume":"256-257","author":"Sardou-Cezar","year":"2021","journal-title":"Cancer Genet"},{"issue":"11","key":"10.1016\/j.clml.2024.12.018_bib0007","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1182\/blood.V95.11.3273","article-title":"Therapy-related acute myeloid leukemia and myelodysplasia after high-dose chemotherapy and autologous stem cell transplantation","volume":"95","author":"Pedersen-Bjergaard","year":"2000","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clml.2024.12.018_bib0008","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/bmt.2014.325","article-title":"Secondary malignancies following high dose therapy and autologous hematopoietic cell transplantation-systematic review and meta-analysis","volume":"50","author":"Vaxman","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"5","key":"10.1016\/j.clml.2024.12.018_bib0009","doi-asserted-by":"crossref","first-page":"E80","DOI":"10.1002\/ajh.23966","article-title":"Characteristics and outcome of therapy-related myeloid neoplasms: rreport from the Italian network on secondary leukemias","volume":"90","author":"Fianchi","year":"2015","journal-title":"Am J Hematol"},{"issue":"12","key":"10.1016\/j.clml.2024.12.018_bib0010","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00277-018-3462-y","article-title":"A monocentric retrospective study of 138 therapy-related myeloid neoplasms","volume":"97","author":"Claerhout","year":"2018","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.clml.2024.12.018_bib0011","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1182\/blood-2013-07-512657","article-title":"Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study Group","volume":"123","author":"Eichenauer","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.clml.2024.12.018_bib0012","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3324\/haematol.2008.005157","article-title":"Therapy-related myeloid neoplasms","volume":"94","author":"Larson","year":"2009","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.clml.2024.12.018_bib0013","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/bmt.2015.6","article-title":"Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015","volume":"50","author":"Sureda","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.clml.2024.12.018_bib0014","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-2936","article-title":"Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003-2007 versus 2013-2017 cohorts","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann Intern Med"},{"issue":"9","key":"10.1016\/j.clml.2024.12.018_bib0015","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1182\/blood-2009-10-249128","article-title":"Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia","volume":"115","author":"Litzow","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.clml.2024.12.018_bib0016","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.clml.2024.12.018_bib0017","doi-asserted-by":"crossref","unstructured":"Moola S., Munn Z., Tufanaru C., Aromataris E., et al. Systematic reviews of etiology and risk (2020). Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. JBI; 2024. Available from: https:\/\/synthesismanual.jbi.global. https:\/\/doi.org\/10.46658\/JBIMES-24-06.","DOI":"10.46658\/JBIRM-17-06"},{"key":"10.1016\/j.clml.2024.12.018_bib0018","unstructured":"Web Plot Digitizer. Available from: https:\/\/apps.automeris.io\/wpd\/."},{"key":"10.1016\/j.clml.2024.12.018_bib0019","unstructured":"P, S. MetaSurvival: mmeta-analysis of a single survival curve using the multivariate methodology of DerSimonian and Laird. R package version 0.1.0 (2022). . Available from: https:\/\/github.com\/shubhrampandey\/metaSurvival."},{"issue":"4","key":"10.1016\/j.clml.2024.12.018_bib0020","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.6498","article-title":"Assessment of median and mean survival time in cancer clinical trials","volume":"6","author":"Das","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clml.2024.12.018_bib0021","series-title":"Stata Statistical Software: Release 17","year":"2021"},{"issue":"1","key":"10.1016\/j.clml.2024.12.018_bib0022","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health"},{"issue":"7414","key":"10.1016\/j.clml.2024.12.018_bib0023","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.clml.2024.12.018_bib0024","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/sim.4780070807","article-title":"A note on graphical presentation of estimated odds ratios from several clinical trials","volume":"7","author":"Galbraith","year":"1988","journal-title":"Stat Med"},{"issue":"47","key":"10.1016\/j.clml.2024.12.018_bib0025","first-page":"15","article-title":"Assessing the influence of a single study in the meta-anyalysis estimate","volume":"8","author":"Tob\u00edas","year":"1999","journal-title":"Stata Technical Bulletin"},{"issue":"7","key":"10.1016\/j.clml.2024.12.018_bib0026","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1177\/21925682221110527","article-title":"Fixed-effect vs random-effects models for meta-analysis: 3 points to consider","volume":"12","author":"Dettori","year":"2022","journal-title":"Global Spine J"},{"issue":"9","key":"10.1016\/j.clml.2024.12.018_bib0027","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/bmt.2015.151","article-title":"Outcomes of patients with therapy-related AML\/myelodysplastic syndrome (t-AML\/MDS) following hematopoietic cell transplantation","volume":"50","author":"Alam","year":"2015","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1016\/j.clml.2024.12.018_bib0028","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.3324\/haematol.2017.172544","article-title":"Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status","volume":"102","author":"Aldoss","year":"2017","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.clml.2024.12.018_bib0029","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood.V89.7.2578","article-title":"Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy","volume":"89","author":"Anderson","year":"1997","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.clml.2024.12.018_bib0030","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1007\/s00277-023-05356-6","article-title":"Poor outcome of allogeneic transplantation for therapy-related acute myeloid leukemia induced by prior chemoradiotherapy","volume":"102","author":"Araie","year":"2023","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.clml.2024.12.018_bib0031","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/bmt.2010.20","article-title":"Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapy","volume":"45","author":"Armand","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.clml.2024.12.018_bib0032","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bmt.1700971","article-title":"Bone marrow transplantation for therapy-related myelodysplasia: comparison with primary myelodysplasia","volume":"20","author":"Ballen","year":"1997","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.clml.2024.12.018_bib0033","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41409-023-01970-0","article-title":"Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study","volume":"58","author":"Baranwal","year":"2023","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.clml.2024.12.018_bib0034","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1182\/blood-2007-02-076307","volume":"110","author":"Chang","year":"2007","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clml.2024.12.018_bib0035","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1046\/j.1365-2141.2000.02200.x","article-title":"Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)","volume":"110","author":"De Witte","year":"2000","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.clml.2024.12.018_bib0036","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/bmt.2015.338","article-title":"Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation","volume":"51","author":"Finke","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.clml.2024.12.018_bib0037","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41409-019-0673-3","article-title":"Transplant outcomes for patients with therapy-related acute myeloid leukemia with prior lymphoid malignancy: an ALWP of EBMT study","volume":"55","author":"Gatwood","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1016\/j.clml.2024.12.018_bib0038","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/hon.2991","article-title":"Outcome of therapy-related myelodysplastic syndrome and oligoblastic acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: a propensity score matched analysis","volume":"40","author":"Itonaga","year":"2022","journal-title":"Hematol Oncol"},{"issue":"12","key":"10.1016\/j.clml.2024.12.018_bib0039","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.bbmt.2019.07.013","article-title":"Allogeneic stem cell transplantation in therapy-related myelodysplasia after autologous transplantation for lymphoma: a retrospective study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy","volume":"25","author":"Jaimes-Albornoz","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"8","key":"10.1016\/j.clml.2024.12.018_bib0040","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.bbmt.2020.04.004","article-title":"Outcome and risk factors for therapy-related myeloid neoplasms treated with allogeneic stem cell transplantation in Japan","volume":"26","author":"Kida","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"3","key":"10.1016\/j.clml.2024.12.018_bib0041","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.bbmt.2011.11.009","article-title":"Allogeneic hematopoietic stem cell transplantation for pediatric patients with treatment-related myelodysplastic syndrome or acute myelogenous leukemia","volume":"18","author":"Kobos","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.clml.2024.12.018_bib0042","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3324\/haematol.2008.000927","article-title":"Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation","volume":"94","author":"Kr\u00f6ger","year":"2009","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.clml.2024.12.018_bib0043","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ajh.25395","volume":"94","author":"Lee","year":"2019","journal-title":"Am J Hematol"},{"issue":"3","key":"10.1016\/j.clml.2024.12.018_bib0044","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12890","article-title":"Outcomes of children, adolescents, and young adults following allogeneic stem cell transplantation for secondary acute myeloid leukemia and myelodysplastic syndromes-the MD Anderson Cancer Center experience","volume":"21","author":"Maher","year":"2017","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1016\/j.clml.2024.12.018_bib0045","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2018.005","article-title":"Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: monocentric observational study and review of the literature","volume":"10","author":"Metafuni","year":"2018","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"11","key":"10.1016\/j.clml.2024.12.018_bib0046","doi-asserted-by":"crossref","first-page":"923.e1","DOI":"10.1016\/j.jtct.2021.08.010","article-title":"Allogeneic transplantation to treat therapy-related myelodysplastic syndrome and acute myelogenous leukemia in adults","volume":"27","author":"Metheny","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"7","key":"10.1016\/j.clml.2024.12.018_bib0047","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41409-022-01686-7","article-title":"Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT","volume":"57","author":"Nabergoj","year":"2022","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.clml.2024.12.018_bib0048","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.hemonc.2021.03.003","article-title":"Predictors of outcomes of therapy-related acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Nampoothiri","year":"2022","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"10","key":"10.1016\/j.clml.2024.12.018_bib0049","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/bmt.2008.226","article-title":"Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML","volume":"42","author":"Nevill","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.clml.2024.12.018_bib0050","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.bbmt.2019.05.038","article-title":"Secondary acute myeloid leukemia and the role of allogeneic stem cell transplantation in a population-based setting","volume":"25","author":"Nilsson","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"10.1016\/j.clml.2024.12.018_bib0051","first-page":"1683","article-title":"Allogeneic hematopoietic stem cell transplantation overcomes the poor prognosis in MLL-rearranged solid tumor therapy related-acute myeloid leukemia","volume":"11","author":"Qi","year":"2021","journal-title":"Am J Cancer Res"},{"issue":"7","key":"10.1016\/j.clml.2024.12.018_bib0052","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.bbmt.2018.04.008","article-title":"Transplant Outcomes for secondary acute myeloid leukemia: acute leukemia Working Party of the European Society for blood and Bone marrow Transplantation Study","volume":"24","author":"Sengsayadeth","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.clml.2024.12.018_bib0053","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/leu.2015.122","article-title":"Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment","volume":"30","author":"Sevcikova","year":"2016","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.clml.2024.12.018_bib0054","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3109\/10428194.2011.603445","article-title":"Allogeneic stem cell transplantation in therapy-related acute myeloid leukemia and myelodysplastic syndromes: impact of patient characteristics and timing of transplant","volume":"53","author":"Spina","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2024.12.018_bib0055","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.leukres.2016.05.005","article-title":"Allogeneic hematopoietic cell transplantation for adult patients with treatment-related acute myeloid leukemia during first remission: comparable to de novo acute myeloid leukemia","volume":"47","author":"Tang","year":"2016","journal-title":"Leuk Res"},{"issue":"8","key":"10.1016\/j.clml.2024.12.018_bib0056","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1200\/JCO.2001.19.8.2134","article-title":"Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia","volume":"19","author":"Witherspoon","year":"2001","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clml.2024.12.018_bib0057","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.2000.18.5.963","article-title":"Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantation","volume":"18","author":"Yakoub-Agha","year":"2000","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.clml.2024.12.018_bib0058","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/bmt.2012.58","article-title":"Chronic GVHD is associated with lower relapse risk irrespective of stem cell source among patients receiving transplantation from unrelated donors","volume":"47","author":"Signori","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.clml.2024.12.018_bib0059","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41409-020-0813-9","article-title":"Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHD","volume":"55","author":"Salas","year":"2020","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.clml.2024.12.018_bib0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024024686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265024024686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T19:32:51Z","timestamp":1751398371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265024024686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2152265024024686"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2024.12.018","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Myeloid Neoplasms: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2024.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}